Study on the correlation between serum inflammatory factor levels and fatigue in Parkinson's patients

Cohort study clinical trial to assess whether serum inflammatory cytokine levels correlate with fatigue in patients with Parkinson's disease and predict poor prognosis in patients with Parkinson's disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043275

Enrollment

Unknown

Registered

2021-02-09

Start date

2021-02-10

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Parkinsons disease fatigue patients, Parkinsons non-fatigue patients and healthy people :Nil

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: The diagnosis of primary Parkinson's disease meets the diagnostic criteria of the British Parkinson's Disease Association Brain Bank.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had any other neurological diseases, infectious diseases or autoimmune diseases, visual and/or hearing deficits, or had used corticosteroids, anti-inflammatory drugs or antibiotics within the four weeks prior to the study.

Design outcomes

Primary

Measure	Time frame
Serum inflammatory factors;	—

Secondary

Measure	Time frame
Fatigue Scale Score;	—

Countries

China

Contacts

Public ContactYingzhu Chen

Affiliated Hospital of Yangzhou University

yzchendr@163.com+86 18051061299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026